Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

HaEmek Medical Center, Israel

Status: Completed

Conditions: Hydrops in Keratoconus

Treatments: Drug: Gas SF6 (Sulfur Hexafluoride)

Study type: Interventional

Funder types: Other

Identifiers

NCT00593190

0097-07-EMC

Details and patient eligibility

About

Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

Enrollment: 8 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hydrops

Exclusion criteria

• Age < 18 years old

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

1

Experimental group

Treatment:

Drug: Gas SF6 (Sulfur Hexafluoride)